Challenges presented by the COVID-19 pandemic can be even more stressful and overwhelming for people living with chronic illnesses. As a trusted resource for the multiple sclerosis (MS) community, the Multiple Sclerosis Association of America (MSAA) is committed to providing accurate, up-to-date information, and resources during this time. Webinars about COVID-19 and Multiple Sclerosis Streamed […]
Read News ArticleAuthor: Hoff Communications
Understanding the COVID-19 Impact on MS in People of Color
Featuring Mitzi Joi Williams, MD The effects of COVID-19 in the United States has disproportionately impacted the health of racial and ethnic minority populations, especially within the African American and Hispanic communities. Presented on May 14, 2020 with the most updated information available at the time of broadcast, MS expert neurologist Mitzi Williams, MD, provides […]
Read News ArticleWhat You Need to Know About COVID-19 and MS – Program 4
Featuring Barry Hendin, MD and Carrie Hersh, DO, MSc Streamed live on May 11, 2020, this fourth program in our ongoing series of webinars addressing the COVID-19 pandemic features MSAA’s Chief Medical Officer Barry Hendin, MD and the Chair of MSAA’s Healthcare Advisory Council Carrie Hersh, DO, MSc providing the latest updates and insights on […]
Read News ArticleNew MRI Application: Thank You
Thank you for submitting your application to MSAA. Please allow MSAA up to two weeks from the date of this message to review and process your application. Please know we will contact you by phone, email, or letter. Please do not schedule an appointment for your MRI(s) until you hear from MSAA directly. If you […]
Read News ArticlePast MRI Reimbursement Application: Thank You
Thank you for submitting your application to MSAA. Please allow MSAA up to two weeks from the date of this message to review and process your application. Please know we will contact you by phone, email, or letter. If you have any questions, please call us (800) 532-7667, ext. 120.
Read News ArticleThe Coronavirus and MS
The coronavirus disease 2019 (COVID-19) is a potentially serious respiratory disease first reported overseas in late 2019 and then spread to the United States in early 2020. The ongoing COVID-19 pandemic has greatly impacted the United States and presents a number of questions and concerns for those affected by multiple sclerosis (MS). As this rapidly […]
Read News ArticleBafiertam™ Oral Capsules Approved by the FDA for Relapsing Forms of MS
On April 30, 2020, Banner Life Sciences LLC (Banner), a privately held specialty pharmaceutical company, announced the United States Food and Drug Administration (FDA) approval of Bafiertam™ (monomethyl fumarate) delayed-release oral capsules to treat relapsing forms of multiple sclerosis (MS). This approval includes the treatment of clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), and active secondary-progressive MS (SPMS). Banner has not yet announced when the medication will be available to the MS community.
Read News ArticleThe Motivator 2019 Archives
MSAA’s magazine highlights and explains many vital issues of importance to our readers affected by MS. These include cover and feature stories about a variety of topics such as depression, assistive technology, the role of pets and service animals, parents with MS, and clinical trials, to name a few. Columns appearing in each issue include […]
Read News ArticleWhat You Need to Know About COVID-19 and MS – Program 3
Featuring Barry Hendin, MD and Carrie Hersh, DO, MSc This April 27, 2020 live webinar features MSAA’s Chief Medical Officer Barry Hendin, MD and the Chair of MSAA’s Healthcare Advisory Council Carrie Hersh, DO, MSc providing the latest news and updates at the time of broadcast on the coronavirus and its impact on multiple sclerosis. […]
Read News Article